Benin Management CORP Sells 197 Shares of UnitedHealth Group Incorporated $UNH

Benin Management CORP reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 15.8% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,048 shares of the healthcare conglomerate’s stock after selling 197 shares during the quarter. Benin Management CORP’s holdings in UnitedHealth Group were worth $327,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Brookstone Capital Management boosted its holdings in shares of UnitedHealth Group by 29.8% in the 2nd quarter. Brookstone Capital Management now owns 17,251 shares of the healthcare conglomerate’s stock worth $5,382,000 after purchasing an additional 3,960 shares in the last quarter. Studio Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 2.3% in the 2nd quarter. Studio Investment Management LLC now owns 7,427 shares of the healthcare conglomerate’s stock worth $2,317,000 after purchasing an additional 165 shares in the last quarter. Private Capital Advisors Inc. boosted its holdings in shares of UnitedHealth Group by 1.6% in the 2nd quarter. Private Capital Advisors Inc. now owns 37,685 shares of the healthcare conglomerate’s stock worth $11,757,000 after purchasing an additional 608 shares in the last quarter. D.A. Davidson & CO. boosted its holdings in shares of UnitedHealth Group by 33.7% in the 2nd quarter. D.A. Davidson & CO. now owns 56,801 shares of the healthcare conglomerate’s stock worth $17,720,000 after purchasing an additional 14,315 shares in the last quarter. Finally, Blume Capital Management Inc. boosted its holdings in shares of UnitedHealth Group by 954.3% in the 2nd quarter. Blume Capital Management Inc. now owns 3,068 shares of the healthcare conglomerate’s stock worth $957,000 after purchasing an additional 2,777 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. KeyCorp upped their price objective on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Wells Fargo & Company increased their target price on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of UnitedHealth Group in a report on Wednesday, October 8th. Eighteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Hold” and an average price target of $385.13.

UnitedHealth Group Trading Up 0.3%

UNH opened at $365.47 on Wednesday. The business has a 50 day simple moving average of $333.70 and a two-hundred day simple moving average of $341.28. The firm has a market capitalization of $331.00 billion, a price-to-earnings ratio of 15.83, a PEG ratio of 2.36 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the previous year, the company earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.